CD38 and neoplasm: Our findings showed that the CD38/CD47 BsAbs strongly blocked the CD47/SIRPα interaction in CD38/CD47 double-positive tumor cells, indicating that the inhibition of CD47/SIRPα depended on the engagement of CD38.